Fatoumata Samassa

发表

Shigella impairs human T lymphocyte responsiveness by hijacking actin cytoskeleton dynamics and T cell receptor vesicular trafficking

J. Husson, J. Tinevez, P. Sansonetti, 2020, Cellular microbiology.

Self-antigens, benign autoimmunity and type 1 diabetes: a beta-cell and T-cell perspective

R. Mallone, Fatoumata Samassa, 2022, Current opinion in endocrinology, diabetes, and obesity.

Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses

P. Sansonetti, A. Phalipon, Fatoumata Samassa, 2019, Human vaccines & immunotherapeutics.

In Vitro and In Vivo Analysis of the Gram-Negative Bacteria–Derived Riboflavin Precursor Derivatives Activating Mouse MAIT Cells

O. Lantz, M. Hervé, D. Mengin-Lecreulx, 2015, The Journal of Immunology.

Glycan-Glycan Interaction Determines Shigella Tropism toward Human T Lymphocytes

P. Sansonetti, C. Parsot, G. Dubey, 2018, mBio.

CD8+ T Cells Variably Recognize Native Versus Citrullinated GRP78 Epitopes in Type 1 Diabetes

S. Buus, C. Mathieu, D. Eizirik, 2021, Diabetes.

Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes

P. Sansonetti, Z. Porat, C. Parsot, 2017, Proceedings of the National Academy of Sciences.

Interferon-α promotes neo-antigen formation and preferential HLA-B-restricted antigen presentation in pancreatic β-cells

P. Marchetti, D. Eizirik, M. Colli, 2023, bioRxiv.

Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses

P. Sansonetti, A. Phalipon, Fatoumata Samassa, 2019, Human vaccines & immunotherapeutics.